SuperworthHims & Hers Health EPS HIMS
Diluted earnings per share by quarter and over the last twelve months, from 2019.
- Last 12 months, to Jun 30, 2026
- −$0.63
- Latest quarter, Q2 FY26
- −$0.37
- −318% on a year earlier
- Fiscal year 2025
- $0.51
- −6% on the year before
Hims & Hers Health's earnings per share was −$0.63 over the twelve months to Jun 30, 2026, down 179% on a year earlier.
In its latest quarter, Q2 FY26, it was −$0.37, down 318% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.51 | −6% |
| FY2024 | $0.54 | n/a |
| FY2023 | −$0.11 | n/a |
| FY2022 | −$0.32 | n/a |
| FY2021 | −$0.62 | n/a |
| FY2020 | −$0.51 | n/a |
| FY2019 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.37 | −318% | −$0.63 | |
| Q1 FY26 | −$0.40 | −300% | −$0.09 | |
| Q4 FY25 | $0.08 | −27% | $0.51 | |
| Q3 FY25 | $0.06 | −81% | $0.54 | |
| Q2 FY25 | $0.17 | +183% | $0.80 | |
| Q1 FY25 | $0.20 | +300% | $0.69 | |
| Q4 FY24 | $0.11 | +1000% | $0.54 | |
| Q3 FY24 | $0.32 | n/a | $0.44 | |
| Q2 FY24 | $0.06 | n/a | $0.08 | |
| Q1 FY24 | $0.05 | n/a | −$0.01 | |
| Q4 FY23 | $0.01 | n/a | −$0.11 | |
| Q3 FY23 | −$0.04 | n/a | −$0.17 |
Against its peers
Companies in Medical - Care Facilities nearest Hims & Hers Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HIMSHims & Hers Health | −$0.63 | −179% a year |
| CHEChemed | $19.92 | +2% a year |
| PACSPACS | $1.75 | +113% a year |
| SHCSotera Health | $0.57 | +613% a year |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| LFSTLifeStance Health | $0.13 | |
| OPCHOption Care Health | $1.33 | +6% a year |
| ENSGEnsign | $6.38 | +16% a year |
| UHSUniversal Health Services | $24.55 | +29% a year |
| NHCNational Healthcare | $8.89 | +32% a year |
| DVADavita | $12.22 | +20% a year |
| Peer median | $4.07 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Hims & Hers Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.